Technology
Health
Pharmaceutical

scPharmaceuticals

$2.87
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (1.06%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SCPH and other stocks, options, ETFs, and crypto commission-free!

About

scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. Read More The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Employees
23
Headquarters
Burlington, Massachusetts
Founded
2013
Market Cap
52.74M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
69.51K
High Today
$2.94
Low Today
$2.84
Open Price
$2.84
Volume
13.69K
52 Week High
$15.70
52 Week Low
$2.76

Collections

Technology
Health
Pharmaceutical
2017 IPO
US
North America

Earnings

-$0.80
-$0.62
-$0.45
-$0.27
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.44 per share
Actual
-$0.27 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.